Interactive Transcript
0:01
This was an infant who presented at Day of Life six,
0:05
who at prenatal ultrasound had a question
0:08
of a cystic left kidney.
0:11
So they came for postnatal renal ultrasound
0:13
to further evaluate that left kidney.
0:16
On the very first image,
0:17
we can see there's something abnormal.
0:19
So we see normal part of normal liver
0:23
and then we see part of
0:24
what looks like a normal right kidney.
0:26
But then we have this heterogeneous mass lesion
0:29
above the right kidney, which is kind of funny
0:31
because this patient presented with concern
0:34
for contralateral left sided abnormality.
0:37
So here we have normal right kidney,
0:39
but again, this abnormal heterogeneous lesion in
0:42
the senal space.
0:44
Interestingly, we see part of one limb of the adrenal gland.
0:48
Um, this does not appear
0:50
to be arising from the left kidney itself
0:52
because we do not have a claw sign of this left kidney.
0:56
Um, sorry, right kidney.
0:58
This looks completely separate from the right kidney.
1:01
We don't have a claw of tissue.
1:03
And circling this, we see only part of normal adrenal gland.
1:07
So this is gonna be an adrenal primary lesion.
1:10
We see some normal portion of hypertrophy,
1:13
normal hypertrophied adrenal gland,
1:16
but then we have this heterogeneous mass lesion, um,
1:19
occupying the other limb of the adrenal gland.
1:23
So the question is, is this gonna be a solid lesion?
1:26
Can we find internal flow
1:27
or is this just an avascular adrenal hematoma related
1:31
to birth injury?
1:34
And so we'll put color doppler flow
1:36
to be able to distinguish that.
1:38
And unfortunately this, um, uh,
1:41
heterogeneous mass lesion arising from the right adrenal
1:43
gland does appear to have internal vascularity.
1:48
So right away, just based on these few images we've seen,
1:51
this is gonna be concerning for congenital neuroblastoma.
1:55
Um, let's see what other images we have.
1:58
Yeah, this is definitely real flow to this
2:02
SRE mass lesion involving the right adrenal gland.
2:05
So this is highly concerning for congenital neuroblastoma.
2:09
So from here we're gonna recommend that our clinicians, uh,
2:12
number one, refer or involve the pediatric
2:15
or pediatric oncology colleagues that they get, um,
2:18
urine catecholamine levels.
2:20
Um, in this case, I'll tell you that they were elevated.
2:23
I'll spoil the surprise.
2:25
And then, um, several other things need to happen.
2:28
Number one, um, usually when you have a tumor
2:31
that presents at such a young age,
2:34
the prognosis is, uh, worse.
2:37
But neuroblastoma is the opposite.
2:39
When you have an infant that presents either
2:41
with congenital neuroblastoma
2:43
or any infant prior to the age of 18 months,
2:47
they actually typically have a better prognosis.
2:49
So that is called stage, um, MS in the, um,
2:55
INSS staging system.
2:57
Um, so this patient will go on number one
3:00
to soft tissue sampling of this lesion to confirm
3:03
that is neuroblastoma,
3:05
but then also to do molecular analysis of this tumor.
3:08
They'll look for en IC amplification to be able
3:10
to additionally help them prognosticate in this tumor.
3:14
And then the last thing that will happen is staging
3:16
with MIBG.
3:18
Um, so looking for additional areas of uptake to be sure
3:22
that this patient doesn't need to be upstaged, um, uh, to,
3:26
uh, a higher stage of neuroblastoma continuing
3:30
through this kidney, uh, renal ultrasound just to make sure
3:32
that whatever cystic structure they saw in the left kidney
3:35
prenatally is either real or not real.
3:38
We have a normal urinary bladder, normal, uh,
3:41
heterogeneous content in the rectum.
3:43
This is a normal thickness
3:45
of a urinary bladder in an infant.
3:46
It's just not super well distended.
3:49
Oh no, the left kidney was indeed abnormal.
3:52
So that right adrenal neuroblastoma
3:54
was an incidental finding.
3:56
So let's grade this left-sided, uh,
3:59
hydronephrosis based on the UTD classification system.
4:02
Number one, we have ectasis Number two,
4:05
we have not only central,
4:07
but we also have peripheral ectasis.
4:09
And then I would say that this renal parenchyma is
4:12
diffusely, but, but, uh, smoothly thin.
4:16
So this is renal parenchymal thinning.
4:18
So this is left urinary tract dilatation P three
4:22
because of that renal parenchymal thinning.
4:25
So this patient will go on, uh, uh,
4:27
to be followed not only from a neuroblastoma standpoint,
4:30
but also from a congenital hydro necrosis
4:33
follow-up standpoint.
4:35
But the next thing we're gonna do
4:36
for this infant is follow up MIBG.
4:40
So these are images from the follow-up MIBG
4:42
that this patient underwent.
4:44
And I'm going to just show you these whole body, um,
4:47
planar images to show you all the, all the areas of uptake.
4:51
So I'm gonna magnify this, um, this, uh,
4:54
coronal view here for you.
4:56
So MIBG will have physiologic uptake to salivary glands.
5:00
We'll see normal uptake in several areas,
5:03
but this is abnormal MIBG uptake associated with
5:07
that right adrenal primary neuroblastoma.
5:10
Other places that you wanna play close attention to to look
5:13
for other, uh, uh, abnormal MIBG uptake areas, uh,
5:18
is the bone marrow.
5:19
So, uh, this is a localized right adrenal, uh,
5:24
primary only neuroblastoma.
5:27
When we assign a curie score to this infant, um,
5:30
there will only be one point for a soft tissue component,
5:35
but there is no abnormal bone marrow uptake.
5:37
So curie score of one.
5:40
So this patient will be followed, um,
5:42
because this is a low risk neuroblastoma, obviously.
5:46
Um, they also have to correlate
5:47
with the en ic applica amplification status,
5:50
but we just have a localized primary tumor.
5:53
Oftentimes they will watch these tumors. They won't even
5:56
Surgically resect them, and they will involute on their
5:59
own if it doesn't change in size or if it grows over time.
6:03
As they follow these patients per the COG uh, treatment,
6:06
children's oncology group treatment protocols, um, they, uh,
6:11
may end, eventually end up resecting the
6:13
primary adrenal tumor.
6:15
Um, but if it's, if it's well-behaved,
6:18
they often spontaneously resolve when patients present
6:21
with congenital neuroblastoma.
6:23
So this is one of those tumors that it's not the end
6:26
of the world to be born with.
6:27
Oftentimes patients
6:29
with congenital neuroblastoma have excellent prognosis, um,
6:33
like this patient.